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Background: There is still uncertainty about the optimal strategy in patients with multivessel disease undergoing primary PCI for cardiogenic 
shock. Therefore we compared outcome of patients with culprit lesion only PCI and immediate multivessel PCI for cardiogenic shock in real life.
methods: We used the data of the prospective ALKK-PCI registry and included patients with primary PCI for cardiogenic shock with 2-3 vessel 
disease. We excluded patients with left main PCI and patients with prior coronary artery bypass surgery.
results: Between 2008 and 2010 a total of 742 patients 2-3 vessel disease were treated with primary PCI for cardiogenic shock. Of these 176 
(24%) received immediate multivessel PCI while in the remaining only the culprit vessel was treated.
Baseline characteristics, procedural features and outcomes are given in the table. 
Culprit lesion PCI
(n=566)
Multivessel PCI
(n=176)
p-value
Age (years) 70.3 68.1 0.2
Diabetes 38 % 35 % 0.5
Renal insuffiency 50 % 39 % 0.01
STEMI 77 % 69 % 0.02
3-vessel disease 62 % 69 % 0.7
TIMI 3 after PCI 80 % 82 % 0.3
IABP 26 % 33 % 0,03
Contrast medium (ml) 170 228 < 0.001
Inhospital Ddeath 35.6 % 46.9 % 0.007
conclusion: Immediate multivessel PCI for cardiogenic shock used in about 25 % of patients is associated with similar success rates as culprit 
lesion PCI, but with a higher mortality. Therefore a randomized trial seems warranted to evaluate the optimal interventional strategy in these 
patients.
